SUMMARY: "For the first time, the US Federal Drug Administration today has approved a drug produced in a genetically engineered plant cell. Among those cheering the news are scientists who have advocated ‘bio-pharming’. The drug, Elelyso (taliglucerase alfa), soothes the symptoms in most patients of the rare lysosomal storage disorder Gaucher disease, which causes problems ranging from bone infections to anaemia.
SOURCE: The Center for Food Safety, USA
AUTHOR: Press Release
Cera Products, Inc. Will Not Market Products That Contain Ventria's Genetically Engineered Rice Compounds
New Law May Prohibit Ventria from Marketing its Lead Drug in Food Products
NORTH SACRAMENTO-BASED VENTRIA SOWING A STORM WITH ALTERED RICE
SOURCE: Sacramento Bee, USA
AUTHOR: Jim Downing
In a little town in Kansas, Sacramento's Ventria Bioscience is about to turn one of the biotechnology industry's long-held dreams and one of its critics' nightmares into reality.
For 14 years, Ventria has inched toward its vision of growing fields of genetically modified rice plants that would serve as cheap factories for medicine.
Comments needed regarding USDA/APHIS Federal Docket No. APHIS-2007-0027 on genetically engineered (GE) Eucalyptus Tree Field Trials in Alabama: First US mainland release of flowering GE trees.
DEADLINE: MONDAY, MAY 21, 2007, 5pm Eastern
ArborGen seeks permission for GE Eucalyptus Field Trials of genetically engineered cold tolerant clones and GE Eucalyptus trees with confidential traits in Alabama. Published articles and industry reports indicate these traits likely include insect resistance and reduced lignin.
Plan to Plant Gene-Modified Rice Alarms Interest Groups
by Megan Tady
Apr. 27 A government agency is currently weighing a controversial proposal to allow a biotechnology company to plant up to 3,200 acres of rice genetically modified to treat diarrhea.